| ACTHAR Gel for Cutaneous Sarcoidosis: An Open Label Trial (NCT02348905) | Albany Medical College | 2015-03-01 |
| Simplified Versus Conventional Technique for Complete Denture Fabrication. (NCT02652403) | Universidade Federal do Rio Grande do Norte | 2015-03-01 |
| Investigation of Intranasal Oxytocin on Relapse Risk in Cocaine-dependent Patients. (NCT02255357) | New York State Psychiatric Institute | 2015-03-01 |
| Ketamine for Thrombolysis in Acute Ischemic Stroke (NCT02258204) | University Hospital, Caen | 2015-03-01 |
| Rituximab, Eltrombopag and Dexamethasone as Frontline Treatment for Immune Thrombocytopenia (NCT02834286) | Hospital Universitario Dr. Jose E. Gonzalez | 2015-03-01 |
| Immunomodulation to Optimize Vascularized Composite Allograft Integration for Limb Loss Therapy (NCT02310867) | Linda Cendales | 2015-03-01 |
| Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy (NCT02223819) | Columbia University | 2015-03-01 |
| A Phase 1/2 Trial of Donor Regulatory T-cells for Steroid-Refractory Chronic Graft-versus-Host-Disease (NCT02385019) | Instituto de Medicina Molecular João Lobo Antunes | 2015-03-01 |
| Regorafenib in Reducing Recurrence in Patients With Non-metastatic Rectal Cancer Who Have Completed Curative-Intent Treatment (NCT02287727) | Roswell Park Cancer Institute | 2015-03-01 |
| Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer (NCT02009605) | Zhejiang University | 2015-03-01 |
| The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction (NCT02696577) | Assiut University | 2015-03-01 |
| Regorafenib in Metastatic Colorectal Cancer (NCT02466009) | University of Rochester | 2015-03-01 |
| Faecal Microbiota Transplantation in Irritable Bowel Syndrome (NCT02423421) | University College Cork | 2015-03-01 |
| Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis. (NCT02097849) | Biogen | 2015-02-28 |
| Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101) (NCT02393248) | Incyte Corporation | 2015-02-27 |
| Removal of Beta Blocker Drugs by Hemodialysis (NCT03361280) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2015-02-27 |
| Maintenance Tegafur-uracil in Resected Oral Cavity Cancer With ECS+ (NCT03121313) | Chang Gung Memorial Hospital | 2015-02-26 |
| A Study of ASP2215 in Combination With Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia. (NCT02310321) | Astellas Pharma Inc | 2015-02-26 |
| Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma (NCT02336165) | Ludwig Institute for Cancer Research | 2015-02-26 |
| Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303） (NCT02388919) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-02-26 |
| A Study to Evaluate the Safety and Efficacy of Topically Applied TV 45070 Ointment in Patients With Postherpetic Neuralgia (PHN) (NCT02365636) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-02-26 |
| A Randomized, Blinded, Placebo-controlled, Phase II Trial of LEE011 in Patients With Relapsed, Refractory, Incurable Teratoma With Recent Progression (NCT02300987) | Novartis Pharmaceuticals | 2015-02-26 |
| PReoperative Chemoradiation (Paclitaxel-carboplatin or FOLFOX) for Resectable Esophageal and Junctional Cancer (NCT02359968) | Centre Oscar Lambret | 2015-02-26 |
| Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine (NCT02475278) | Takeda | 2015-02-26 |
| Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer (NCT02315196) | Rutgers, The State University of New Jersey | 2015-02-25 |
| Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021 (NCT02342548) | Pfizer | 2015-02-25 |
| Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (NCT02122185) | University of Chicago | 2015-02-25 |
| Efficacy and Safety of CR6261 in an H1N1 Influenza Healthy Volunteer Human Challenge Model (NCT02371668) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-25 |
| NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis (NCT02371681) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-25 |
| Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases (NCT02248597) | Wake Forest University Health Sciences | 2015-02-25 |
| Evaluation of Pazopanib on Bleeding in Subjects With Hereditary Haemorrhagic Telangiectasia (NCT02204371) | GlaxoSmithKline | 2015-02-25 |
| Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052) (NCT02335424) | Merck Sharp & Dohme LLC | 2015-02-24 |
| Valganciclovir Therapy in Infants and Children With Congenital CMV Infection and Hearing Loss (NCT01649869) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-24 |
| Ponatinib for Patients Whose Advanced Solid Tumor Cancer Has Activating Mutations Involving the Following Genes: FGFR1, FGFR2, FGFR3, FGFR4, RET, KIT. (NCT02272998) | Sameek Roychowdhury | 2015-02-24 |
| Valproic Acid Plus Cisplatin and Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of Head and Neck (NCT02624128) | National Cancer Institute, Naples | 2015-02-23 |
| Early Treatment of Acute Graft Versus Host Disease With Bone Marrow-Derived Mesenchymal Stem Cells and Corticosteroids (NCT02379442) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-02-23 |
| IMT for Primary Clostridium Difficile Infection (NCT02301000) | Oslo University Hospital | 2015-02-22 |
| Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan (NCT02272803) | Bristol-Myers Squibb | 2015-02-20 |
| ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (NCT02362035) | Acerta Pharma BV | 2015-02-20 |
| Metformin in Non Small Cell Lung Cancer (NSCLC) (NCT02285855) | M.D. Anderson Cancer Center | 2015-02-20 |
| Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas (NCT02332980) | Mayo Clinic | 2015-02-19 |
| Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection (NCT02210078) | M.D. Anderson Cancer Center | 2015-02-19 |
| A Study to Characterize the PK and PD Profile of IV FCM in Pediatric Subjects 1-17 Years Old With IDA (NCT02410213) | American Regent, Inc. | 2015-02-19 |
| Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery (NCT02291432) | Cook MyoSite | 2015-02-19 |
| Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine For The First Line Treatment of Pancreas Cancer (NCT03807999) | Hacettepe University | 2015-02-19 |
| An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB) (NCT02365623) | Janssen Pharmaceutical K.K. | 2015-02-18 |
| The Continuation of Gefitinib Treatment Beyond Progression in Non-small Cell Lung Cancer Patients With EGFR Mutation (NCT03399669) | Samsung Medical Center | 2015-02-17 |
| A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast Cancer (NCT02301988) | Genentech, Inc. | 2015-02-17 |
| A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Onychomycosis of the Toenail (NCT02267356) | Viamet | 2015-02-17 |
| Cabozantinib S-malate in Treating Patients With Metastatic Pheochromocytomas or Paragangliomas That Cannot Be Removed by Surgery (NCT02302833) | M.D. Anderson Cancer Center | 2015-02-17 |
| Adult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade Gliomas (NCT02343406) | AbbVie | 2015-02-17 |
| Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection (NCT02378935) | Gilead Sciences | 2015-02-17 |
| Anesthesia Feasibility Study With the CONCERT-CL® Station (NCT02889718) | Institut Cancerologie de l'Ouest | 2015-02-16 |
| Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Non-Genotype 1 HCV Infection (NCT02378961) | Gilead Sciences | 2015-02-16 |
| A Clinical Study of Alanyl-Glutamine for Reduction of Post-Myomectomy Adhesions (NCT01701193) | Temple Therapeutics BV | 2015-02-15 |
| Niraparib Versus Niraparib-bevacizumab Combination in Women With Platinum-sensitive Epithelial Ovarian Cancer (NCT02354131) | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | 2015-02-15 |
| Benfotiamine in Alzheimer's Disease: A Pilot Study (NCT02292238) | Burke Medical Research Institute | 2015-02-15 |
| Add-on Peginterferon Following Nucleos(t)Ide Analogue Treatment (NCT02364336) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-02-14 |
| Azacytidine Prior to in Vivo T-cell Depleted Allo Stem Cell Transplant for Patients With Myeloid Malignancies in CR (NCT02497404) | Weill Medical College of Cornell University | 2015-02-13 |
| Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngeal Carcinoma (NCT02269943) | Celgene | 2015-02-13 |
| Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life (NCT02333435) | CHU de Quebec-Universite Laval | 2015-02-12 |
| Safety and Efficacy of Telapristone Acetate (Proellex®) Administered Vaginally for the Treatment of Uterine Fibroids (NCT02323646) | Repros Therapeutics Inc. | 2015-02-12 |
| Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer (NCT02187991) | US Oncology Research | 2015-02-12 |
| Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis (NCT02727907) | Biocad | 2015-02-12 |
| Ruxolitinib Phosphate and Decitabine in Treating Patients With Relapsed or Refractory or Post Myeloproliferative Acute Myeloid Leukemia (NCT02257138) | M.D. Anderson Cancer Center | 2015-02-12 |
| Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy (NCT02449655) | Samsung Medical Center | 2015-02-12 |
| Antioxidant Therapy in RYR1-Related Congenital Myopathy (NCT02362425) | National Institute of Nursing Research (NINR) | 2015-02-12 |
| Reducing Proviral HIV DNA With Interferon-a (NCT02227277) | The Wistar Institute | 2015-02-11 |
| Trial of Ra-223 Dichloride in Combination With Hormonal Therapy and Denosumab in the Treatment of Patients With Hormone-Positive Bone-Dominant Metastatic Breast Cancer (NCT02366130) | M.D. Anderson Cancer Center | 2015-02-11 |
| Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer (NCT02316340) | The University of Texas Health Science Center at San Antonio | 2015-02-11 |
| Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery (NCT02249949) | Alliance for Clinical Trials in Oncology | 2015-02-11 |
| Bortezomib in Rejection of Kidney Transplants (NCT02201576) | Assistance Publique - Hôpitaux de Paris | 2015-02-11 |
| Study of RS1 Ocular Gene Transfer for X-linked Retinoschisis (NCT02317887) | VegaVect, Inc. | 2015-02-11 |
| A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection) (NCT02267382) | Viamet | 2015-02-10 |
| Selenium and Arsenic Pharmacodynamics (NCT02377635) | University of Saskatchewan | 2015-02-10 |
| Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer (NCT02323126) | Novartis Pharmaceuticals | 2015-02-09 |
| Denosumab for Breast Cancer With Bone Mets (NCT01952054) | M.D. Anderson Cancer Center | 2015-02-09 |
| Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) (NCT02177136) | Intercept Pharmaceuticals | 2015-02-09 |
| Pembrolizumab +/- Bevacizumab for Recurrent GBM (NCT02337491) | Dana-Farber Cancer Institute | 2015-02-09 |
| ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial (NCT02326350) | Belfast Health and Social Care Trust | 2015-02-06 |
| Sorafenib Plus 5-Azacitidine Initial Therapy of Patients With Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MS) With FLT3-ITD Mutation (NCT02196857) | M.D. Anderson Cancer Center | 2015-02-06 |
| Single Dose Study to Evaluate the Safety, and Efficacy of S-1226 (8%) in Subjects With Mild Atopic Asthma (NCT02334553) | SolAeroMed Inc. | 2015-02-06 |
| CCFZ533X2201 - PoC Study in de Novo Renal Transplantation (NCT02217410) | Novartis Pharmaceuticals | 2015-02-05 |
| A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections (NCT02321800) | Shionogi | 2015-02-05 |
| Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy (NCT02291237) | Gilead Sciences | 2015-02-05 |
| Analyze the Predictive Value of Gene TMPRSS2-ETS in Response to Enzalutamide in Patients With Prostate Cancer (NCT02288936) | Spanish Oncology Genito-Urinary Group | 2015-02-05 |
| An Open Label Phase 2 Study of ManNAc in Subjects With GNE Myopathy (NCT02346461) | National Human Genome Research Institute (NHGRI) | 2015-02-05 |
| Study of REGN1500 in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (NCT02265952) | Regeneron Pharmaceuticals | 2015-02-04 |
| Clinical Trial to Evaluate Safety and Efficacy of CCX168 in ANCA-Associated Vasculitis (NCT02222155) | Amgen | 2015-02-04 |
| Treatment of Refractory Hemochromatosis Rheumatism by Anakinra: a Preliminary Phase II Study (NCT02263638) | Rennes University Hospital | 2015-02-04 |
| A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations (NCT02299635) | Pfizer | 2015-02-03 |
| Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy (NCT02042391) | Diako Ev. Diakonie-Krankenhaus gemeinnützige GmbH | 2015-02-03 |
| A Study of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With or Without Sofosbuvir and Ribavirin in Direct-Acting Antiviral Agent Treatment-Experienced Adults With Chronic Hepatitis C Virus Infection (NCT02356562) | AbbVie | 2015-02-03 |
| A Study of Pembrolizumab (MK-3475) in Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (MK-3475-059/KEYNOTE-059) (NCT02335411) | Merck Sharp & Dohme LLC | 2015-02-03 |
| Efficacy and Safety of Talimogene Laherparepvec Neoadjuvant Treatment Plus Surgery Versus Surgery Alone for Melanoma (NCT02211131) | Amgen | 2015-02-03 |
| Clinical Study to Assess the Safety, Tolerability and Efficacy of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension (NCT02060721) | Actelion | 2015-02-03 |
| Pre-operative Zoledronate in Triple Negative Breast Cancer (NCT02347163) | Mario Negri Institute for Pharmacological Research | 2015-02-03 |
| Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (NCT02270814) | Washington University School of Medicine | 2015-02-02 |
| A Safety and Immune Response Study of 2 Experimental HIV Vaccines (NCT02404311) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-02-02 |
| Human Umbilical Cord Stroma MSC in Myocardial Infarction (NCT02323477) | Ankara University | 2015-02-02 |